METHOD OF OBTAINING ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE

Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ARENSON DANIEL RAY, BUSCH FRANK ROBERT, RASADI BIJAN, HAUSBERGER ANGELA CAROL GATLIN
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.